Fix Your Funds

Delving into the portfolios of Australia's top investors unveils a selection of ASX shares that have caught their attention. While inclusion in these esteemed portfolios doesn't guarantee success, it offers valuable insights into stocks that are deemed promising by industry experts. Image Credit: Pexels Aristocrat Leisure Limited ( ASX: ALL ) Aristocrat Leisure stands as a prominent player in the global gaming industry, specializing in poker machines, casino management systems, and mobile games publishing. Notably, it has secured a position among the most widely-held stock picks, as indicated by leading fund managers such as DNR Capital's High Conviction Strategy. With a positive outlook for FY24, driven by anticipated growth in underlying net profit after tax (NPATA), Aristocrat Leisure is positioned for market-leading performance. The ASX share's valuation, based on Commsec estimates, reflects a favorable earnings multiple, underlining its potential for growth and val...

Investing in stocks often involves navigating fluctuations in share prices, but a rising share price doesn't necessarily mean a company has lost its value. Resmed CDI ( ASX: RMD ) serves as a prime example of this principle, with its share price making a notable recovery since its October 2023 lows. Despite the significant uptick, there's still ample potential for further gains. Image Credit: Pexels Resmed's Impressive Recovery Resmed, a prominent provider of respiratory devices for treating obstructive sleep apnea (OSA), has experienced a remarkable resurgence in its share price. From its lowest point in October 2023 at $21.14, the company's shares have surged by 41% to reach their current level of $29.90. Additionally, Resmed is an ASX healthcare stock . Valuation and Growth Prospects While Resmed shares may no longer be trading at bargain basement prices, with a price-to-earnings (P/E) ratio of 32 times FY2024 earnings, the company remains in line with the global me...

Investors in the Australian stock market have been closely monitoring the performance of CSL Ltd (ASX: CSL) and Resmed CDI ( ASX: RMD ) shares, both of which operate in the healthcare sector. Despite recent fluctuations in their share prices, these companies continue to play significant roles in providing innovative healthcare solutions globally. Image Credit: Pexels CSL Ltd: A Leader in Biotechnology CSL Ltd is a renowned global biotechnology company known for developing and delivering life-saving medicines. With a focus on addressing life-threatening medical conditions, CSL operates through three main business units: CSL Behring, CSL Seqirus, and CSL Vifor. CSL Behring specializes in manufacturing and distributing blood plasma products, while CSL Seqirus focuses on flu-related products and pandemic-related services. CSL Vifor develops products for iron deficiency and nephrology. Business Operations and Acquisitions ASX:CSL relies on plasma and blood collections to support its prima...

Image Credit: Pexels ResMed, a global leader in sleep and respiratory care solutions, has recently experienced a decline in its share price on a Wednesday. Several factors may contribute to such price movements, and it's important for investors to understand the potential reasons behind this fluctuation. In this article, we will explore some common reasons why ResMed's share price ( ASX RMD )might slide on a Wednesday. Market Sentiment and Macro Factors: One of the key drivers of stock price movements is overall market sentiment and macroeconomic factors. If there is negative news or uncertainty in the broader financial markets on a Wednesday, it can lead to a decline in share prices across the board, including ResMed. Economic indicators, political events, and global economic conditions can all impact investor sentiment. Company-Specific News: Company-specific news can have a significant impact on a stock's price. ResMed may release announcements or reports that affect inv...

  Image Credit: Pexels Investing in ASX 200 shares is a popular choice for many investors, and when these shares go ex-dividend, it's a significant event. Not only does it mean that investors will soon receive a dividend, but it's also associated with a typical share price drop. So, what exactly happens when an ASX 200 share trades ex-dividend? Let's break it down. An ex-dividend date is the day when new investors are essentially excluded from receiving the upcoming dividend. In simpler terms, if you own the shares before the ex-dividend date, you'll be in line for the dividend payment. However, if you acquire them on or after the ex-dividend date, you'll miss out on the dividend. The consequence of this is a noticeable decrease in the company's share price. This decline reflects the perceived loss of value for investors who won't receive the dividend. In this article, we'll discuss three ASX 200 shares set to go ex-dividend next week.\ Champion Iron Lt...